Nucleoside analog inhibitors of reverse transcriptase

Raven H. Huang (Inventor), Xianjun Liu (Inventor)

Research output: Patent

Abstract

Compounds of formula (XXIII), or pharmaceutically acceptable salts or esters thereof, are inhibitors of reverse transcriptase:

@misc{503a7f69783c4e449afc8d318da40df0,

title = "Nucleoside analog inhibitors of reverse transcriptase",

abstract = "Compounds of formula (XXIII), or pharmaceutically acceptable salts or esters thereof, are inhibitors of reverse transcriptase:",

author = "Huang, \{Raven H.\} and Xianjun Liu",

year = "2009",

month = jun,

day = "23",

language = "English (US)",

type = "Patent",

note = "7550442",

}

TY - PAT

T1 - Nucleoside analog inhibitors of reverse transcriptase

AU - Huang, Raven H.

AU - Liu, Xianjun

PY - 2009/6/23

Y1 - 2009/6/23

N2 - Compounds of formula (XXIII), or pharmaceutically acceptable salts or esters thereof, are inhibitors of reverse transcriptase:

AB - Compounds of formula (XXIII), or pharmaceutically acceptable salts or esters thereof, are inhibitors of reverse transcriptase:

M3 - Patent

M1 - 7550442

Y2 - 2004/05/19

ER -